Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56491 | 0.86 | CA2 (0.58) | CA2GABRA1GABRB2RIPK1ALDH1A1 | |
| SCHEMBL7619218 | 0.81 | CNR2 (0.42) | CA2RECQLEGFRERBB2 | |
| SCHEMBL2916950 | 0.80 | CA2 (0.71) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL4493446 | 0.80 | CA2 (0.46) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL2047673 | 0.79 | CA2 (0.70) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL10608749 | 0.79 | RIPK1 (0.39) | CA2RIPK1ALDH1A1TSHRTDP1 | |
| SCHEMBL57364 | 0.78 | GABRA1 (0.64) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL56747 | 0.78 | GABRA1 (0.61) | CA2GABRA1GABRB2RIPK1ALDH1A1 | |
| SCHEMBL574123 | 0.77 | ALDH1A1 (0.42) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL24512510 | 0.77 | GABRA1 (0.48) | CA2GABRA1GABRB2RIPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4551195-A1 | CANNABINOID LIPID PREMIXTURE | Fertin Pharma A/S (DK) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025067622-A1 | CANNABIDIOL FOR USE IN ALLEVIATING XEROSTOMIA | FERTIN PHARMA A/S (DK) | 2025-04-03 | — | — | WO | disclosed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| EP-4088716-B1 | AN ORAL TABLET FOR INDUCED SALIVA GENERATION | FERTIN PHARMA AS (DK) | 2024-10-16 | — | — | EP | disclosed |
| US-5575652-A | Process for applying antibacterial oral composition to dental implant areas | COLGATE PALMOLIVE COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| US-5538715-A | DENTIFRICES WITH ANTIPLAQUE AGENTS FOR MOUTHS WITH HUMECTANTS, SILICA POLISHES AND BACTERICIDES | COLGATE PALMOLIVE COMPANY (US) | 1996-07-23 | — | — | US | disclosed |
| US-5288480-A | Antiplaque antibacterial oral composition | COLGATE-PALMOLIVE CO. (US) | 1994-02-22 | — | — | US | disclosed |
| US-5192530-A | Solubilizer, enhancing agent to aid retention, and delivery enhancement | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5080887-A | Polyphosphate, bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | CA2 1688/4885GABRA1 3441/4885GABRB2 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.